Praidou Anna, Androudi Sofia, Brazitikos Periklis, Karakiulakis George, Papakonstantinou Eleni, Tsinopoulos Ioannis, Dimitrakos Stavros
St. Paul's Eye Unit, Royal Liverpool University Hospital, L7 8XP, UK ; Department of Ophthalmology, Aristotle University, 54124 Thessaloniki, Greece.
Department of Ophthalmology, Aristotle University, 54124 Thessaloniki, Greece.
J Diabetes Res. 2014;2014:158251. doi: 10.1155/2014/158251. Epub 2014 Jul 17.
To identify any possible relation between glycaemic control and previous laser photocoagulation for diabetic retinopathy.
Seventy-two patients with diabetes were included in the study and were separated into 2 groups according to previous treatment (group A) or not (group B) with argon laser photocoagulation. Glycaemic control was estimated by measuring blood levels of HbA1c in four consecutive measurements.
Blood levels of HbA1c in group A were significantly lower 3, 6, and 12 months after laser treatment as compared to blood levels of HbA1c before laser treatment (7.1 ± 0.4% versus 7.6 ± 0.9%, 7.2 ± 0.2% versus 7.6 ± 0.9%, and 7.1 ± 0.2% versus 7.6 ± 0.9%, resp., all P < 0.05). Blood levels of HbA1c in group B did not differ significantly in four consecutive measurements.
Our results suggest that we should anticipate a better glycaemic control in cases of patients with diabetes previously treated with laser photocoagulation.
确定血糖控制与糖尿病视网膜病变既往激光光凝治疗之间的任何可能关系。
72例糖尿病患者纳入本研究，根据既往是否接受氩激光光凝治疗分为两组（A组）或未接受治疗组（B组）。通过连续四次测量HbA1c的血水平来评估血糖控制情况。
与激光治疗前的HbA1c血水平相比，A组在激光治疗后3个月、6个月和12个月时的HbA1c血水平显著降低（分别为7.1±0.4%对7.6±0.9%、7.2±0.2%对7.6±0.9%、7.1±0.2%对7.6±0.9%，均P<0.05）。B组在连续四次测量中HbA1c血水平无显著差异。
我们的结果表明，对于既往接受激光光凝治疗的糖尿病患者，应预期其血糖控制会更好。
